Skip to main navigation Skip to search Skip to main content

Characterization of c-Kit expression and activation in KSHV-infected endothelial cells

  • Janet L. Douglas
  • , Jill G. Whitford
  • , Ashlee V. Moses

Research output: Contribution to journal › Article › peer-review

Abstract

Kaposi's sarcoma (KS) herpesvirus (KSHV) is the etiological agent of several immunodeficiency-linked cancers, including KS. Our previous work showed that the proto-oncogene c-kit is upregulated in KSHV-infected endothelial cells (ECs), as well as in KS lesions. We show here that KSHV-dependent induction of both c-kit mRNA and protein requires the establishment of a latent infection and that this upregulation occurs in primary DMVECs as well as in immortalized DMVECs (eDMVECs). Interestingly, we find that while the lymphatic EC (LEC) subpopulation exhibits KSHV-induced c-Kit upregulation, the blood EC (BEC) subpopulation does not. Despite this upregulation of c-Kit, receptor activation and phosphorylation of downstream effectors such as MAP Kinase Erk 1/2 and GSK-3 still requires the addition of exogenous c-Kit ligand, stem cell factor (SCF). These data indicate that KSHV does not induce constitutive c-Kit signaling, but instead upregulates c-Kit receptor levels, thus allowing infected ECs to respond to endogenous and exogenous SCF. Nonetheless, inhibition of either c-Kit activation or its downstream effectors reverses the characteristic spindle phenotype of infected eDMVECs. Together, these results contribute to our overall understanding of the role that the c-kit proto-oncogene plays in KS pathogenesis.

Original languageEnglish (US)
Pages (from-to)174-185
Number of pages12
JournalVirology
Volume390
Issue number2
DOIs
StatePublished - Aug 1 2009

Funding

This research was supported by National Institutes of Health Grants CA099906 and RR00163. This manuscript is the sole responsibility of the authors and does not necessarily represent the official views of the NIH. Funding for this research was also provided by a grant from the Collins Medical Trust (J.D.).

FundersFunder number
Author National Institutes of Health National Institutes of Health National Institutes of Health National Institutes of Health The Bev Hartig Huntington's Disease Foundation National Institutes of HealthRR00163
National Institute of Health-National Cancer InstituteR01CA099906
Collins Medical Trust

    Keywords

    • Endothelial cells
    • Herpesvirus 8
    • KSHV
    • Kaposi's sarcoma
    • Viral transformation
    • c-kit

    ASJC Scopus subject areas

    • Virology

    Fingerprint

    Dive into the research topics of 'Characterization of c-Kit expression and activation in KSHV-infected endothelial cells'. Together they form a unique fingerprint.

    Cite this